Skip to main content
MedVellum
QuestionsVideosPricing

MedVellum

Fellowship exam preparation across every specialty: source-verified topics, questions in every format, and videos.

Product

  • Specialties
  • Questions
  • Videos
  • Exam tools
  • Pricing

Verification & policy

  • Verified register
  • Editorial policy
  • Privacy
  • Terms

Account

  • Sign in
  • Create account
  • Dashboard
  • Account & billing

© 2026 MedVellum. For education only — not a substitute for clinical judgement.

llms.txtPsychiatry LLM catalogSitemap

ICU TopicsRespiratory / airway emergencies

ICU · Respiratory / airway emergencies

Acute Massive Haemoptysis — Comprehensive ICU Management

Also known as Massive haemoptysis · Life-threatening haemoptysis · Massive hemoptysis · Pulmonary haemorrhage · Bronchial artery embolisation · Rigid bronchoscopy haemostasis · Ice-cold saline lavage · Double-lumen tube lung isolation · Rasmussen aneurysm · Aspergilloma haemoptysis

Acute massive haemoptysis is a respiratory emergency in which the patient dies of ASPHYXIATION, not exsanguination — a small volume of blood can rapidly flood the airways, abolish gas exchange, and cause hypoxaemic arrest long before the circulating volume is lost. Define it functionally as any bleeding that causes significant haemodynamic decompensation or respiratory distress that may lead to death if left untreated; volume-based definitions vary widely (anywhere from 100 to 1,000 mL per 24 hours has been considered significant, and fewer than 5 to 15 per cent of haemoptysis episodes are massive). Around 90 per cent of brisk bleeding arises from the BRONCHIAL (systemic, high-pressure) circulation and under 10 per cent from the pulmonary artery. Management is a fixed cascade: (1) protect the airway, isolate the non-bleeding lung, and keep the patient bleeding-side-down; (2) intubate with a large-bore single-lumen tube that admits a bronchoscope, or a double-lumen tube/bronchial blocker; (3) bronchoscopy — rigid preferred for massive bleeding — for cold saline lavage, topical vasoconstriction, and balloon tamponade; (4) bronchial artery embolisation (BAE), the first-line endovascular therapy, with pooled clinical success around 93 per cent (65-92 per cent depending on cause) and recurrence in roughly a quarter; (5) surgery for failure, unavailability, or localised lesions. Mortality across series is 9-38 per cent. This topic maps the cascade and the evidence behind every step.

high18 referencesUpdated 19 Aug 202617 min readSource-verified · Oct 2026

Checked against its sources on 14 Oct 2026

Practise this topic

  • 8 MCQs

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Death is from ASPHYXIATION, not exsanguination — a small amount of blood can rapidly flood the airways and abolish gas exchange; airway protection dominates everything else
  • Isolate the non-bleeding lung and keep the bleeding side dependent — gravity keeps blood in the bleeding lung and spares the good lung
  • Intubate with a large-bore single-lumen tube that admits a bronchoscope, or a double-lumen tube/bronchial blocker for lung isolation
  • Bronchial artery embolisation (BAE) is the first-line definitive endovascular therapy — pooled clinical success around 93 per cent with recurrence in roughly a quarter; mobilise interventional radiology early
  • Around 90 per cent of brisk bleeding is from the systemic BRONCHIAL circulation (high pressure); under 10 per cent from the pulmonary artery
  • Mycetoma/aspergilloma suffered the highest relapse and mortality after BAE in classic series — plan for recurrence
On this page
Study tools

Your progress

Saved on this device.

Practise this topic8 MCQs with explanations

Target exams

CICMFFICMEDIC

Red flags

  • Death is from ASPHYXIATION, not exsanguination — a small amount of blood can rapidly flood the airways and abolish gas exchange; airway protection dominates everything else
  • Isolate the non-bleeding lung and keep the bleeding side dependent — gravity keeps blood in the bleeding lung and spares the good lung
  • Intubate with a large-bore single-lumen tube that admits a bronchoscope, or a double-lumen tube/bronchial blocker for lung isolation
  • Bronchial artery embolisation (BAE) is the first-line definitive endovascular therapy — pooled clinical success around 93 per cent with recurrence in roughly a quarter; mobilise interventional radiology early
  • Around 90 per cent of brisk bleeding is from the systemic BRONCHIAL circulation (high pressure); under 10 per cent from the pulmonary artery
  • Mycetoma/aspergilloma suffered the highest relapse and mortality after BAE in classic series — plan for recurrence
In one line

Acute massive haemoptysis is any bleeding that causes significant haemodynamic decompensation or respiratory distress that may lead to death if left untreated — the functional definition; volume definitions vary from 100 to 1,000 mL per 24 hours.[9] The patient dies of ASPHYXIATION, not exsanguination — a small amount of blood rapidly floods the airways and abolishes gas exchange[7][11] — so airway protection dominates everything else. Run the fixed cascade: (1) secure the airway and isolate the non-bleeding lung, with the bleeding side dependent[10]; (2) intubate with a large-bore single-lumen tube that admits a bronchoscope, or a double-lumen tube / bronchial blocker to isolate the bleeding lung[7]; (3) bronchoscopy — rigid preferred for controlling massive bleeding[3] — for cold saline lavage[5], endobronchial vasoconstrictor (adrenaline)[14], and balloon tamponade[18]; (4) bronchial artery embolisation (BAE) by interventional radiology — the first-line endovascular therapy, with clinical success of 65-92 per cent depending on cause and about 93 per cent pooled[2][12]; (5) surgery for BAE failure, unavailability, or localised lesions.[3]

Definition — what makes haemoptysis "massive"

Haemoptysis is massive (also called life-threatening) when the volume or the rate of bleeding threatens the airway and gas exchange. There is no single universally agreed volume threshold — reviews put massive episodes at fewer than 5 per cent[1] to 5-15 per cent[3] of all haemoptysis presentations, and any amount between 100 and 1,000 mL per day has been considered significant.[9] The spectrum the examiner should know:

  • Scant / mild — blood-streaked sputum; usually self-limiting (haemoptysis is usually a self-limiting event[1]), investigated as an outpatient if persistent.
  • Moderate — requires admission, observation, and workup (imaging ± bronchoscopy); the triage level at which most randomised tranexamic-acid trials enrolled (Wand excluded anything over 200 mL per 24 hours as "massive").[15]
  • Volume-based "massive" definitions — texts variously use more than 100 mL per day up to 1,000 mL per day; the range itself is the exam point.[9]
  • Any amount that threatens the airway — the modern functional definition: "any amount of haemoptysis that causes significant hemodynamic decompensation or respiratory distress which may lead to death if left untreated".[9] Up to 15 per cent of haemoptysis cases are life-threatening and need urgent intervention.[9]
The functional definition — airway threat beats millilitres

The single most important conceptual point: define massive haemoptysis by threat to the airway, not by a volume cut-off. A small-volume but brisk bleed from a bronchial artery can flood the airways and impair oxygenation and ventilation, "leading to asphyxia and consequent cardiovascular collapse", while a slow ooze of the same total volume may be tolerated.[7] Contemporary reviews define life-threatening haemoptysis functionally — any amount causing haemodynamic decompensation or respiratory distress that may lead to death if untreated[9] — and this is the definition that drives the cascade below.

ICU Fellowship (CICM) Pro

Continue reading

You have read the opening of this topic. The complete unit — every section and its primary-source references — is part of the ICU Fellowship (CICM) fellowship library.

Sign in to continueSee pricing
References18ShowHide
  1. [1]Larici AR, Franchi P, Occhipinti M, Contegiacomo A, del Ciello A, Calandriello L, Storto ML, Marano R, Bonomo L. Diagnosis and management of hemoptysis Diagn Interv Radiol, 2014.PMID 24808437
  2. [2]Khalil A, Fedida B, Parrot A, Haddad S, Fartoukh M, Carette MF. Severe hemoptysis: From diagnosis to embolization Diagn Interv Imaging, 2015.PMID 26141487
  3. [3]Sakr L, Dutau H. Massive hemoptysis: an update on the role of bronchoscopy in diagnosis and management Respiration, 2010.PMID 20090288
  4. [4]Hsiao EI, Kirsch CM, Kagawa FT, Wehner JH, Jensen WA, Baxter RB. Utility of fiberoptic bronchoscopy before bronchial artery embolization for massive hemoptysis AJR Am J Roentgenol, 2001.PMID 11566690
  5. [5]Conlan AA, Hurwitz SS. Management of massive haemoptysis with the rigid bronchoscope and cold saline lavage Thorax, 1980.PMID 7268664
  6. [6]Razazi K, Parrot A, Khalil A, Djibre M, Gounant V, Assouad J, Carette MF, Fartoukh M, Cadranel J. Severe haemoptysis in patients with nonsmall cell lung carcinoma Eur Respir J, 2015.PMID 25359349
  7. [7]Davidson K, Shojaee S. Managing Massive Hemoptysis Chest, 2020.PMID 31374211
  8. [8]Kathuria H, Hollingsworth HM, Vilvendhan R, Reardon C. Management of life-threatening hemoptysis J Intensive Care, 2020.PMID 32280479
  9. [9]Deshwal H, Sinha A, Mehta AC. Life-Threatening Hemoptysis Semin Respir Crit Care Med, 2021.PMID 32862418
  10. [10]Atchinson PRA, Hatton CJ, Roginski MA, Backer ED, Long B, Lentz SA. The emergency department evaluation and management of massive hemoptysis Am J Emerg Med, 2021.PMID 34365064
  11. [11]Uflacker R, Kaemmerer A, Neves C, Picon PD. Management of massive hemoptysis by bronchial artery embolization Radiology, 1983.PMID 6828674
  12. [12]Tao Y, Li J, Su R, Zhou M, Zhu H, Sun Z. The efficacy, safety, and related factors of bronchial artery embolization for hemoptysis: a systematic review and meta-analysis with subgroup analysis Cardiovasc Diagn Ther, 2024.PMID 39513143
  13. [13]Sethi D, Iyer TR, Abu-Al-Timen S. Predictors of Recurrence Following Bronchial Artery Embolisation (BAE) for Haemoptysis: A Systematic Review and Evidence Synthesis Analyses Using SWiM Guidelines Cardiovasc Intervent Radiol, 2026.PMID 42414635
  14. [14]Fekri MS, Hashemi-Bajgani SM, Shafahi A, Zarshenas R. Comparing Adrenaline with Tranexamic Acid to Control Acute Endobronchial Bleeding: A Randomized Controlled Trial Iran J Med Sci, 2017.PMID 28360438
  15. [15]Wand O, Guber E, Guber A, Epstein Shochet G, Israeli-Shani L, Shitrit D. Inhaled Tranexamic Acid for Hemoptysis Treatment: A Randomized Controlled Trial Chest, 2018.PMID 30321510
  16. [16]Tsai YS, Hsu LW, Wu MS, Chen KH, Kang YN. Effects of Tranexamic Acid on Hemoptysis: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Clin Drug Investig, 2020.PMID 32661913
  17. [17]HALT-IT Trial Collaborators. Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial Lancet, 2020.PMID 32563378
  18. [18]Feloney JP, Balchum OJ. Repeated massive hemoptysis: successful control using multiple balloon-tipped catheters for endobronchial tamponade Chest, 1978.PMID 367727

Test yourself

Practise what you just read

  • 8 MCQs
ICU Fellowship (CICM) Pro

$29/ monthor $279 / year

The complete ICU Fellowship (CICM) library, every exam format, one subscription.

  • Complete library for one chosen specialty
  • Timed MCQ mock exams and spaced review
  • Clinical cases & cross-table vivas
See pricingSign in
PreviousSevere acute pancreatitis: fluid resuscitation (WATERFALL), necrosis, and PANTER step-upGI and nutritionNextAcute Neutropenic Sepsis — Comprehensive ICU Managementinfectious-diseases